{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:10:41Z","timestamp":1793427041642,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.vaccine.2012.07.056","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T03:00:33Z","timestamp":1344049233000},"page":"6016-6019","source":"Crossref","is-referenced-by-count":171,"title":["Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States"],"prefix":"10.1016","volume":"30","author":[{"given":"Harrell W.","family":"Chesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatus U.","family":"Ekwueme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.056_bib0005","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0010","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2012.07.056_bib0015","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0020","first-page":"e137","article-title":"Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States","volume":"16","author":"Saraiya","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cncr.22487","article-title":"Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS)","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3322\/canjclin.57.2.105","article-title":"Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines","volume":"57","author":"Solomon","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jpepsy\/jsp108","article-title":"Factors influencing familial decision-making regarding human papillomavirus vaccination","volume":"35","author":"Gamble","year":"2010","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0045","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/cncr.23207","article-title":"Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004","volume":"112","author":"Ekwueme","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0050","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1185\/03007990802281671","article-title":"Five-year routine cervical cancer screening rates and intervals in a US health plan","volume":"24","author":"Schabert","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/LGT.0b013e3181ac05e9","article-title":"Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population","volume":"14","author":"Henk","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0065","unstructured":"Saraiya M. Burden of HPV-associated cancers in the United States. Meeting of the Advisory Committee on Immunization Practices, Atlanta, GA; February 24, 2011."},{"key":"10.1016\/j.vaccine.2012.07.056_bib0070","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2008.07.032","article-title":"Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan","volume":"111","author":"Insinga","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0080","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0085","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1185\/03007990903136378","article-title":"Assessing incidence and economic burden of genital warts with data from a US commercially insured population","volume":"25","author":"Hoy","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0090","unstructured":"U.S. Census Bureau, Statistical Abstract of the United States: 2011 (130th Edition) Washington, DC; 2010."},{"key":"10.1016\/j.vaccine.2012.07.056_bib0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/313914","article-title":"Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle","volume":"31","author":"Armstrong","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0100","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.vaccine.2008.06.045","article-title":"The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination","volume":"26","author":"Chesson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archotol.126.8.935","article-title":"The cost of juvenile-onset recurrent respiratory papillomatosis","volume":"126","author":"Bishai","year":"2000","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0110","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomas. A preliminary report","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.07.056_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination","volume":"100","author":"Goldhaber-Fiebert","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2012.07.056_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-0009.2011.00652.x","article-title":"Cervical cancer screening in the United States and the Netherlands: a tale of two countries","volume":"90","author":"Habbema","year":"2012","journal-title":"Milbank Q"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2012.07.056_bib0135","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/cncr.23758","article-title":"Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T12:55:12Z","timestamp":1542804912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":27,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0264410X1201081X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}